Tivic Secures BARDA Meeting for Entolimod in Acute Radiation Syndrome

Tivic Health has secured an exclusive meeting with BARDA's Radiological and Nuclear Medical Countermeasures Program to present clinical data on Entolimod, its potential treatment for acute radiation syndrome. The meeting aims to discuss development pathways and establish program priorities. Tivic is a late-stage therapeutics company focused on treating radiation-induced injury and acute radiation syndrome.